Ren D, Zhang Z, Zheng X, et al. TLR5 expression marks brain boarder associated macrophages and protects neonatal mice from ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely ...

Idiopathic pulmonary fibrosis is a life-threatening lung disease AdAlta’s lead candidate AD-214 is a first-in-class molecule designed to treat IPF Amplia and Cynata therapies also show promise in ...

The organizations support that IPF meets the definition of chronic disease and is currently associated with poor outcomes given difficulties diagnosing the disease at an early stage.

While every person's journey with PF is unique, columnist Sam Kirton stresses the importance of support groups for patients and caregivers.

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...

Programs address the need for disease-modifying therapies targeting root causes of fibrosis Funding will support advancement of CCN-family inhibitor TRX-44 into clinical trials for treatment ...